The aim of the Fund is to achieve capital growth.
Name | % Net Assets |
---|---|
GlaxoSmithKline PLC | 4.7% |
BP PLC | 4.6% |
Royal Dutch Shell PLC | 3.8% |
BG Group PLC | 3.7% |
BT Group PLC | 3.1% |
Rio Tinto PLC | 3.1% |
AstraZeneca PLC | 2.8% |
Imperial Tobacco Group PLC | 2.3% |
British American Tobacco PLC | 2.2% |
Barclays PLC | 2.0% |
Key | % Net Assets |
---|---|
GlaxoSmithKline PLC | 4.7% |
BP PLC | 4.6% |
Royal Dutch Shell PLC | 3.8% |
BG Group PLC | 3.7% |
Other | 83.2% |
Date | 21-Nov-2024 |
---|---|
NAV | 142.44p |
Currency | GBP |
Change | 0.80p |
% | 0.56% |
YTD change | 3.74p |
YTD % | 2.70% |
Fund Inception | 30/09/1985 |
---|---|
Fund Manager | Leigh Harrison |
TER | 1.68 (30-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £2000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 3.75% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.04 |
You are here: research